FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078649069> ?p ?o ?g. }

• W2078649069 endingPage "316" @default.
• W2078649069 startingPage "308" @default.
• W2078649069 abstract "The endogenous mu-opioid receptor agonist, endomorphin (EM)-1, cannot be delivered into the central nervous system (CNS) in sufficient quantity to elicit analgesia when given systemically because it is severely restricted by the blood-brain barrier (BBB). To improve the physicochemical characteristics of EM-1 and subsequently achieve greater BBB permeation, we synthesized a series of EM-1 analogs by combining successful chemical modifications, including N-terminal cationization, C-terminal chloro-halogenation, and unnatural amino acid (d-Ala, Sar, and d-Pro-Gly) substitutions in position 2. Presently, their binding and bioassay activity, lipophilicity, stability, and antinociceptive activity were determined and compared. Guanidino-addition and chloro-halogenation attenuated the mu-receptor affinity to some extent, but they demonstrated differences in the influence on stability. It appeared that guanidino-addition contributed to brain stability enhancement for the greater part, whereas chloro-halogenation together with amino acid substitutions in position 2 was of more importance for the stability enhancement in serum than in brain. Determination of the octanol/buffer coefficient revealed that chloro-halogenation did compromise the decreased lipophilicity caused by guanidino-addition, and introduction of d-Ala as well as d-Pro-Gly, but not Sar, in place of l-Pro(2), also increased the overall lipophilicity to some extent. Among the peptides tested, intracerebroventricular injection of guanidino-[d-Ala(2), p-Cl-Phe(4)]EM-1 showed the strongest analgesia, being 3 times more potent than the parent peptide. We also found that in comparison with EM-1, the four d-Ala-containing tetrapeptides and the chloro-halogenated d-Pro-Gly-containing pentapeptide elicited significant and prolonged central-mediated analgesia upon subcutaneous administration, indicating that more peptides reached the CNS, eliciting greater analgesic effect." @default.
• W2078649069 created "2016-06-24" @default.
• W2078649069 creator A5019299951 @default.
• W2078649069 creator A5022466958 @default.
• W2078649069 creator A5036687874 @default.
• W2078649069 creator A5037679524 @default.
• W2078649069 creator A5070812231 @default.
• W2078649069 creator A5087541589 @default.
• W2078649069 date "2006-06-27" @default.
• W2078649069 modified "2023-10-16" @default.
• W2078649069 title "Utilization of Combined Chemical Modifications to Enhance the Blood-Brain Barrier Permeability and Pharmacological Activity of Endomorphin-1" @default.
• W2078649069 cites W1571625134 @default.
• W2078649069 cites W1692343830 @default.
• W2078649069 cites W1971724091 @default.
• W2078649069 cites W1975262853 @default.
• W2078649069 cites W1980260989 @default.
• W2078649069 cites W1980281407 @default.
• W2078649069 cites W1995240096 @default.
• W2078649069 cites W2009402679 @default.
• W2078649069 cites W2013057796 @default.
• W2078649069 cites W2017952116 @default.
• W2078649069 cites W2032403782 @default.
• W2078649069 cites W2044410319 @default.
• W2078649069 cites W2062970451 @default.
• W2078649069 cites W2074631079 @default.
• W2078649069 cites W2079605395 @default.
• W2078649069 cites W2085508966 @default.
• W2078649069 cites W2086464678 @default.
• W2078649069 cites W2089595455 @default.
• W2078649069 cites W2094311740 @default.
• W2078649069 cites W2094449484 @default.
• W2078649069 cites W2117459976 @default.
• W2078649069 cites W2122534380 @default.
• W2078649069 cites W2125828856 @default.
• W2078649069 cites W4293247451 @default.
• W2078649069 doi "https://doi.org/10.1124/jpet.106.106484" @default.
• W2078649069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16803861" @default.
• W2078649069 hasPublicationYear "2006" @default.
• W2078649069 type Work @default.
• W2078649069 sameAs 2078649069 @default.
• W2078649069 citedByCount "59" @default.
• W2078649069 countsByYear W20786490692012 @default.
• W2078649069 countsByYear W20786490692013 @default.
• W2078649069 countsByYear W20786490692014 @default.
• W2078649069 countsByYear W20786490692015 @default.
• W2078649069 countsByYear W20786490692016 @default.
• W2078649069 countsByYear W20786490692017 @default.
• W2078649069 countsByYear W20786490692018 @default.
• W2078649069 countsByYear W20786490692019 @default.
• W2078649069 countsByYear W20786490692020 @default.
• W2078649069 countsByYear W20786490692021 @default.
• W2078649069 countsByYear W20786490692022 @default.
• W2078649069 countsByYear W20786490692023 @default.
• W2078649069 crossrefType "journal-article" @default.
• W2078649069 hasAuthorship W2078649069A5019299951 @default.
• W2078649069 hasAuthorship W2078649069A5022466958 @default.
• W2078649069 hasAuthorship W2078649069A5036687874 @default.
• W2078649069 hasAuthorship W2078649069A5037679524 @default.
• W2078649069 hasAuthorship W2078649069A5070812231 @default.
• W2078649069 hasAuthorship W2078649069A5087541589 @default.
• W2078649069 hasConcept C116073593 @default.
• W2078649069 hasConcept C126322002 @default.
• W2078649069 hasConcept C170493617 @default.
• W2078649069 hasConcept C178790620 @default.
• W2078649069 hasConcept C185592680 @default.
• W2078649069 hasConcept C201399114 @default.
• W2078649069 hasConcept C202751555 @default.
• W2078649069 hasConcept C2778402981 @default.
• W2078649069 hasConcept C2778938600 @default.
• W2078649069 hasConcept C2779281246 @default.
• W2078649069 hasConcept C515207424 @default.
• W2078649069 hasConcept C529278444 @default.
• W2078649069 hasConcept C55493867 @default.
• W2078649069 hasConcept C65973085 @default.
• W2078649069 hasConcept C71240020 @default.
• W2078649069 hasConcept C71924100 @default.
• W2078649069 hasConcept C86803240 @default.
• W2078649069 hasConcept C98274493 @default.
• W2078649069 hasConceptScore W2078649069C116073593 @default.
• W2078649069 hasConceptScore W2078649069C126322002 @default.
• W2078649069 hasConceptScore W2078649069C170493617 @default.
• W2078649069 hasConceptScore W2078649069C178790620 @default.
• W2078649069 hasConceptScore W2078649069C185592680 @default.
• W2078649069 hasConceptScore W2078649069C201399114 @default.
• W2078649069 hasConceptScore W2078649069C202751555 @default.
• W2078649069 hasConceptScore W2078649069C2778402981 @default.
• W2078649069 hasConceptScore W2078649069C2778938600 @default.
• W2078649069 hasConceptScore W2078649069C2779281246 @default.
• W2078649069 hasConceptScore W2078649069C515207424 @default.
• W2078649069 hasConceptScore W2078649069C529278444 @default.
• W2078649069 hasConceptScore W2078649069C55493867 @default.
• W2078649069 hasConceptScore W2078649069C65973085 @default.
• W2078649069 hasConceptScore W2078649069C71240020 @default.
• W2078649069 hasConceptScore W2078649069C71924100 @default.
• W2078649069 hasConceptScore W2078649069C86803240 @default.
• W2078649069 hasConceptScore W2078649069C98274493 @default.
• W2078649069 hasIssue "1" @default.
• W2078649069 hasLocation W20786490691 @default.

• next